Table 4.
Group number | Dose concentration (mg/kg/day) | Tmax | Cmax | Cmax relative ratio | AUC | AUC relative bio-availability ratio |
---|---|---|---|---|---|---|
2 | 8 (1×) | 1.3 ± 0.5 | 1.93 ± 0.60 | NA | 13.94 ± 6.53 | NA |
3 | 16 (2×) | 1.5 ± 0.5 | 3.64 ± 2.19 | 0.83*, † | 37.16 ± 31.70 | 1.05*, † |
4 | 24(3×) | 1.8 ± 0.5 | 4.03 ± 2.13 | 0.61* | 32.07 ± 15.68 | 0.70*, † |
5 | 40 (5×) | 1.4 ± 0.5 | 3.96 ± 3.32 | 0.33* | 28.70 ± 19.88 | 0.37* |
Cmax observed maximum cyclosporine concentration (day 182) (μg/mL).
Tmax observed time to reach Cmax (h).
AUC, area under the cyclosporine vs. time curve between time 0 and 24 h (Day 182) (hμg/mL).
Relative ratios are related to the 1× group and calculated using dose-normalized values.
NA, not applicable.
Statistical analysis: Significant difference of P ≤ 0.005.
Compared to 1× group
Compared to 5× group.